Platelets (Archived)
Activity
Large Group Session
Large Group Session
Be able to explain the key differences in pathogenesis between venous clots and arterial clots. Be able to describe the role of platelets in hemostasis. Be able to describe mechanisms of thrombocytopenia with a special focus on immune-mediated destruction.
Curriculum Block
Hematology / Medical Foundation 1 / Part 1
- Indicates most relevant
Objectives
General Objectives
- Describe the triggers and steps involved in blood clot formation.
- Describe the physiology and structure of the vascular endothelium.
Tags
Archived
Archived
Cohort Year
2010
Curriculum Block
Hematology
Medical Foundation 1
Part 1
Curriculum Week
Part 1
Discipline
Hematology
McMaster Program Competencies
2.2 Apply biomedical scientific principles fundamental to health care for patients and populations.
MeSH
Blood Cell Count [G09.188.105]
Blood Platelets [A11.118.188]
Endothelial Cells [A11.436.275]
Hemolytic-Uremic Syndrome [C15.378.140.855.925.500]
Hemostasis [G09.188.124.560]
Megakaryocyte Progenitor Cells [A15.378.316.378.590.837.625]
Platelet Aggregation Inhibitors [D27.505.954.502.780]
Platelet Membrane Glycoproteins [D12.776.395.550.625]
Purpura, Thrombocytopenic, Idiopathic [C15.378.140.855.925.750.600]
Purpura, Thrombotic Thrombocytopenic [C15.378.140.855.925.750.680]
Splenectomy [E04.726]
Stem Cells [A11.872]
Thrombocytopenia [C15.378.140.855]
Thrombopoietin [D12.644.276.374.410.240.750]
Thrombosis [C14.907.355.830]
